Analysts Upgrade Drug Stocks HZNP and BMY

Most analysts were already bullish on HZNP

by Josh Selway

Published on Aug 14, 2019 at 10:00 AM

Two names enjoying positive analyst attention this morning are drug concerns Horizon Pharma PLC (NASDAQ:HZNP) and Bristol-Myers Squibb Co (NYSE:BMY). Here's how the shares of HZNP and BMY stocks are trading this morning following the upbeat brokerage notes.

HZNP stock was upgraded to "outperform" from "market perform" at BMO, which also lifted its price target to $36 from $29. This puts BMO alongside the rest of the analysts in coverage on the pharmaceutical name, as seven of the eight had "buy" or "strong buy" recommendations coming into today. BMO's price target is slightly more bullish than the Street average, though, since the consensus 12-month price target is $33.60.

Horizon Pharma was last seen trading down 0.5% at $26.42. The stock is up almost 36% year-to-date and recently found support at the $23 level, site of the February highs, suggesting a layer of technical support is in place.

BMY stock received an upgrade to "overweight" from "neutral" at Atlantic Equities, which views the shares as a value opportunity following their one-year decline of 22.5%. Analysts were basically split coming into today, with five "strong buys" on the books, compared to six "holds."

Bristol-Myers Squibb has managed a 0.8% gain out of the gate to trade at $46.85. Many short sellers have been moving in on the stock, with short interest rising 11.7% in the last reporting period. More than nine days' worth of buying power is now dedicated to short interest, based on average daily trading volumes.     


a schaeffer's exclusive

5 NEW STOCK PICKS

We're celebrating 38 years with this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


What's Next for the American Wealth Gap
Porter Stansberry is predicting a major change in the American economic system.
GDP, Consumer Spending Data in Post-Fed Spotlight
Next week will feature the final second-quarter GDP and fresh housing market data
Oversold Pot Stock Catches a Lift
PRVB stock is eyeing its lowest close in months, while IGC stock is set for a big win
What's Next for the American Wealth Gap
Porter Stansberry is predicting a major change in the American economic system.